Inicio>>Signaling Pathways>> PI3K/Akt/mTOR Signaling>> PI3K>>Gilmelisib

Gilmelisib

Catalog No.GC64778

Gilmelisib es un antineoplÁsico. Gilmelisib es un inhibidor de PI3K (IC50 <1 nM para PI3K p110α) extraÍdo del documento WO2017101847 A1, compuesto 1.

Products are for research use only. Not for human use. We do not sell to patients.

Gilmelisib Chemical Structure

Cas No.: 1845777-61-8

Tamaño Precio Disponibilidad Cantidad
5 mg
459,00 $
Disponible
10 mg
738,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Gilmelisib is an antineoplastic. Gilmelisib is a PI3K inhibitor (IC50

[1]. WO2017101847 A1
[2]. International Nonproprietary Names for Pharmaceutical Substances (INN)

Reseñas

Review for Gilmelisib

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Gilmelisib

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.